Merck & Co. 4Q EPS Meets Est., Ending Streak of Beats
Source: BFW (Bloomberg First Word)
Tickers
MRK US (Merck & Co Inc)
To de-activate this alert, click here
UUID: 7947283
(Bloomberg) -- Merck 4Q adj EPS 89c, est. 89c (range 84c-96c).
Alert: HALISTER- NOTE: Merck has beat EPS ests. every quarter since 1Q 2014 or 11 of past 12 quarters: Bloomberg data
- 4Q rev. $10.12b, est. $10.23b (range $9.98b-$10.51b)
- Januvia/Janumet $1.51b, est. $1.57b
- Keytruda $483m, est. $467.4m
- Sees 2017 adj EPS $3.72-$3.87, hurt by 2% on FX; may not compare to est. $3.84 (range $3.58-$4.20)
- Sees 2017 rev. $38.6b-$40.1b at mid-Jan. exchange rates; may not compare to est. $40.02b (range $38.9b-$43.12b)
- MRK has 15 buys, 7 holds, 1 sell, avg PT $68: Bloomberg data
- Conf. call 8am, (877) 381-5782 pw 32136167; Preview
Source: BFW (Bloomberg First Word)
Tickers
MRK US (Merck & Co Inc)
To de-activate this alert, click here
UUID: 7947283